Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
The Journal of Biological Chemistry|October 15, 1991
Inhibitor stabilization of human immunodeficiency virus type-2 proteinase dimer formationT F Holzman, W E Kohlbrenner, D Weigl, et al.Biochemical and Biophysical Research Communications|March 26, 1998
GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strainsW M Kati, A S Saldivar, F Mohamadi, et al.Applied Microbiology and Biotechnology|May 1, 1992
High-level expression and purification of mature HIV-1 protease in Escherichia coli under control of the araBAD promoterA Taylor, D P Brown, S Kadam, et al.Journal of Virology|August 8, 1998
In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitorA Carrillo, K D Stewart, H L Sham, et al.Biochemical and Biophysical Research Communications|August 31, 1990
Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agaroseJ Rittenhouse, M C Turon, R J Helfrich, et al.Antimicrobial Agents and Chemotherapy|May 17, 2001
Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanineT I Ng, Y Shi, H J Huffaker, et al.Journal of Medicinal Chemistry|February 5, 1993
Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diolD J Kempf, L Codacovi, X C Wang, et al.Bioorganic & Medicinal Chemistry|September 1, 1994
Design of orally bioavailable, symmetry-based inhibitors of HIV proteaseD J Kempf, K C Marsh, L C Fino, et al.Antimicrobial Agents and Chemotherapy|November 1, 1991
Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 proteaseD J Kempf, K C Marsh, D A Paul, et al.Biochemical and Biophysical Research Communications|March 29, 1991
Potent HIV-1 protease inhibitors with antiviral activities in vitroH L Sham, D A Betebenner, N E Wideburg, et al.Pageof 3